BioTelemetry and LifeWatch Agree to Pay $14.7 Million to Settle False Claims Charges

BioTelemetry, owned by Philips, and its subsidiary LifeWatch Services have agreed to pay more than $14.7 million to resolve allegations that they violated the False Claims Act by knowingly submitting claims to federal government programs for a higher level of cardiac monitoring than physicians intended to order.
Source: Drug Industry Daily